1-20 of 75
Scott F. Huntington
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Treatment Patterns, Overall Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients with Mantle Cell Lymphoma (MCL) after Failure of Covalent Btki Treatment

Patrick Squires, Justin T. Puckett, Katherine Elizabeth Ryland, Sachin Kamal-Bahl, Monika Raut, Jalpa A. Doshi, Scott F. Huntington
Journal: Blood
Blood (2023) 142 (Supplement 1): 2326.
https://doi.org/10.1182/blood-2023-181024
Published: 2023
Journal Articles

Healthcare Resource Utilization and Costs Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Contemporary US Claims

Scott F. Huntington, Hsien-Yen Chang, Alex Z. Fu, Christina Loefgren, Xiaoxiao Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2348.
https://doi.org/10.1182/blood-2023-181909
Published: 2023
Journal Articles

Real-World Treatment Patterns and Overall Survival Among Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients: A Retrospective Cohort Study Using Claims Data

Scott F. Huntington, Hsien-Yen Chang, Alex Z. Fu, Christina Loefgren, Xiaoxiao Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2428.
https://doi.org/10.1182/blood-2023-178755
Published: 2023
Journal Articles

Alterations in Immune Cell Composition during First-Line Therapy with Mosunetuzumab for Follicular or Marginal Zone Lymphoma

Adam J Olszewski, Thomas Ollila, Ari Pelcovits, Anna Dorota Chorzalska, John Morgan, Jessica McMahon, Stephen Donnelly, Scott F. Huntington, Matthew Matasar, John L. Reagan, Charles Milrod, Patrycja M. Dubielecka
Journal: Blood
Blood (2023) 142 (Supplement 1): 1651.
https://doi.org/10.1182/blood-2023-181418
Published: 2023
Journal Articles

Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers

Emily Ayers, Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Augustus Qualls, Behzad Amoozgar, Brad S. Kahl, John H. Baird, Pavan Challa, Scott F. Huntington, Jennifer Santos, Steven M. Bair, Mayur S. Narkhede, Shuning Li, Zachary AK Frosch, Carrie I Ho, Stephen D Smith, Allison Winter, Daniel J. Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason T. Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana H. Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Debamita Kundu, Mwanasha Hamuza Merrill, Jennifer L Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 312.
https://doi.org/10.1182/blood-2023-174257
Published: 2023
Journal Articles

Real-World Comparison of Healthcare Costs of Venetoclax-Obinutuzumab Vs. Btki Use Among Elderly U.S. Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L) Setting

Beenish S Manzoor, Scott F. Huntington, Dureshahwar Jawaid, Justin T. Puckett, Nnadozie Emechebe, Arliene Ravelo, Sachin Kamal-Bahl, Jalpa A. Doshi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5085.
https://doi.org/10.1182/blood-2023-177939
Published: 2023
Journal Articles

Real-World Patterns of Targeted Therapy Use in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in the United States: A Longitudinal Study

Enrico De Nigris, Wendy Y. Cheng, Eric M. Sarpong, Siyang Leng, Mohammed Z.H. Farooqui, Uchechukwu Samuel Agu, Maryaline Catillon, Dominique Lejeune, Nathaniel Downes, Lisa Matay, Mei Sheng Duh, Scott F. Huntington
Journal: Blood
Blood (2023) 142 (Supplement 1): 6523.
https://doi.org/10.1182/blood-2023-178660
Published: 2023
Journal Articles

Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib

Jessica M. Stempel, Rong Wang, Rory Michael Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev
Journal: Blood
Blood (2022) 140 (Supplement 1): 11004–11006.
https://doi.org/10.1182/blood-2022-165156
Published: 2022
Journal Articles

Real-World Treatment Patterns and Transfusion Burden Among Newly Diagnosed Older Adults with Acute Myeloid Leukemia

Amer M. Zeidan, Wei-Han Cheng, Rajesh Kamalakar, Catherine Miller, Cat N. Bui, Melissa Montez, Tracy Yee, Zheng Wu, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 3282–3283.
https://doi.org/10.1182/blood-2022-160002
Published: 2022
Journal Articles

Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis

Mengyang Di, Jessica B Long, Iris Isufi, Francine M. Foss, Stuart Seropian, Cary P Gross, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 10818–10819.
https://doi.org/10.1182/blood-2022-164915
Published: 2022
Journal Articles

Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)

Mahek Garg, Scott F. Huntington, Justin Puckett, Sachin Kamal-Bahl, Monika Raut, Katherine Elizabeth Ryland, Jalpa Doshi
Journal: Blood
Blood (2022) 140 (Supplement 1): 10814–10815.
https://doi.org/10.1182/blood-2022-158026
Published: 2022
Journal Articles

Mosunetuzumab with Lenalidomide Augmentation As First-Line Therapy for Follicular (FL) and Marginal Zone Lymphoma (MZL)

Adam J. Olszewski, Scott F. Huntington, Rajat Bannerji, Thomas A. Ollila, Jessica McMahon, Patrycja M Dubielecka
Journal: Blood
Blood (2022) 140 (Supplement 1): 6492–6493.
https://doi.org/10.1182/blood-2022-157463
Published: 2022
Journal Articles

Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1 -Mutant Acute Myeloid Leukemia

Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory Michael Shallis, Nikolai A. Podoltsev, Maximilian F. Stahl, Jessica M. Stempel, Eytan Stein, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2022) 140 (Supplement 1): 319–321.
https://doi.org/10.1182/blood-2022-158465
Published: 2022
Journal Articles

Real-World Practice Patterns and Outcomes Following Bruton Tyrosine Kinase Inhibitors (BTKi) in Older Patients with Mantle Cell Lymphoma (MCL): A Population-Based Analysis

Mengyang Di, Jessica B Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory Michael Shallis, Rong Wang, Jessica M. Stempel, Xiaomei Ma, Scott F. Huntington
Journal: Blood
Blood (2022) 140 (Supplement 1): 10904–10906.
https://doi.org/10.1182/blood-2022-164959
Published: 2022
Journal Articles

Real-World Treatment Patterns and Outcomes after Ibrutinib Discontinuation Among Elderly Medicare Beneficiaries with Chronic Lymphocytic Leukemia: An Observational Study

Scott F. Huntington, Enrico De Nigris, Justin Puckett, Sachin Kamal-Bahl, Mohammed Z.H. Farooqui, Katherine Elizabeth Ryland, Eric Sarpong, Xiaoqin Yang, Jalpa Doshi
Journal: Blood
Blood (2022) 140 (Supplement 1): 7939–7940.
https://doi.org/10.1182/blood-2022-155903
Published: 2022
Journal Articles

Real-World Analysis of Adverse Event Rates after Initiation of Ibrutinib Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia By Ibrutinib Discontinuation Status

Enrico De Nigris, Scott F. Huntington, Justin Puckett, Sachin Kamal-Bahl, Mohammed Z.H. Farooqui, Katherine Elizabeth Ryland, Eric Sarpong, Xiaoqin Yang, Jalpa Doshi
Journal: Blood
Blood (2022) 140 (Supplement 1): 5043–5044.
https://doi.org/10.1182/blood-2022-162744
Published: 2022
Journal Articles

Treatment Utilization Patterns, Health Resource Use, Costs, and Survival in Mantle Cell Lymphoma: A Real-World Analysis of a National Sample of Medicare Beneficiaries

Patrick Squires, Scott F. Huntington, Justin Puckett, Katherine Elizabeth Ryland, Sachin Kamal-Bahl, Monika Raut, Jalpa Doshi
Journal: Blood
Blood (2022) 140 (Supplement 1): 5041–5042.
https://doi.org/10.1182/blood-2022-158036
Published: 2022
Journal Articles

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia

Jan Philipp Bewersdorf, Kishan K. Patel, George Goshua, Rory M. Shallis, Nikolai A. Podoltsev, Scott F. Huntington, Amer M. Zeidan
Journal: Blood
Blood (2022) 139 (11): 1766–1770.
https://doi.org/10.1182/blood.2021014401
Published: 2022
Includes: Supplemental data
Journal Articles

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Clinical Trials & Observations
Victor Manuel Orellana-Noia, Daniel R. Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M. Barlow, Mary-Kate Malecek, Marcus Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana Advani, Timothy J. Voorhees, Anson Snow, Natalie Sophia Grover, Amy Ayers, Jason Romancik, Yuxin Liu, Scott F. Huntington, Julio C. Chavez, Hayder Saeed, Aleksandr Lazaryan, Vikram Raghunathan, Stephen E. Spurgeon, Thomas A. Ollila, Christopher Del Prete, Adam Olszewski, Emily C. Ayers, Daniel J. Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F. Caimi, Timothy Fu, Jieqi Liu, Kevin A. David, Hanan Alharthy, Jennie Law, Reem Karmali, Harsh Shah, Deborah M. Stephens, Ajay Major, Alexandra E. Rojek, Sonali M. Smith, Amulya Yellala, Avyakta Kallam, Shazi Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brian T. Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey Switchenko, Jonathon Cohen, Craig A. Portell
Journal: Blood
Blood (2022) 139 (3): 413–423.
https://doi.org/10.1182/blood.2021012888
Published: 2022
Includes: Supplemental data
Journal Articles

Survival of Mantle Cell Lymphoma in the Era of Bruton Tyrosine Kinase Inhibitors: A Population-Based Analysis

Mengyang Di, Can Cui, Shalin K. Kothari, Amer M. Zeidan, Nikolai Podoltsev, Natalia Neparidze, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington
Journal: Blood
Blood (2021) 138 (Supplement 1): 182.
https://doi.org/10.1182/blood-2021-146417
Published: 2021